MP
Mikhail Pavlov
cs.LGcs.AIcs.CVRenal DialysisBiocompatible Materialscs.CLcs.CYcs.SDeess.ASHemoperfusion
On Valency
published · living versionsW_3seyyh2p·v1 · currentpublished
Evaluating Large Language Models Trained on Code
with Mark Chen, Jerry Tworek, Heewoo Jun, Qiming Yuan +53
1 version
Preprints & journals
10 papers in the corpus · 2002–2024OpenAI o1 System Card2412.16720v2 · OpenAI: Aaron Jaech, Adam Kalai, Adam Lerer et al.2024 · 44 citationsarXiv
GPT-4o System Card2410.21276v1 · OpenAI: Aaron Hurst, Adam Lerer, Adam P. Goucher et al.2024 · 165 citationsarXiv
Evaluating Large Language Models Trained on Code2107.03374v2 · Mark Chen, Jerry Tworek, Heewoo Jun et al.2021 · 1,468 citationsarXivon Valency
Zero-Shot Text-to-Image Generation2102.12092v2 · Aditya Ramesh, Mikhail Pavlov, Gabriel Goh et al.2021 · 1,154 citationsarXiv
Run, skeleton, run: skeletal model in a physics-based simulation1711.06922v2 · Mikhail Pavlov, Sergey Kolesnikov, Sergey M. Plis2017 · 6 citationsarXiv
The next step from high-flux dialysis: application of sorbent technology.11803163 · Winchester, James F, Ronco, Claudio, Brady, James A et al.2003 · 39 citationsBlood purification. 2002;20(1):81-6
Sorbent augmented dialysis systems.12101951 · Winchester, F J, Ronco, C, Salsberg, J et al.2002 · 12 citationsContributions to nephrology. 2002(137):170-80
History of sorbents in uremia.11477746 · Winchester, J F, Ronco, C, Brady, J A et al.2002 · 8 citationsContributions to nephrology. 2001(133):131-9
First clinical experience with an adjunctive hemoperfusion device designed specifically to remove beta 2-microglobulin in hemodialysis.11477749 · Ronco, C, Brendolan, A, Winchester, J F et al.2002 · 15 citationsContributions to nephrology. 2001(133):166-73
Rationale for combined hemoperfusion/hemodialysis in uremia.11477750 · Winchester, J F, Ronco, C, Brady, J A et al.2002 · 8 citationsContributions to nephrology. 2001(133):174-9
Career total: 13 works. 10 are in this corpus.
Profile built from the corpus for this byline.
Author records are still filling in while the Hub is in alpha. If this is your page, you'll be able to claim it soon. Spot a mistake? Tell us.